Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Male Breast Carcinoma|Stage IIA Breast Cancer AJCC v6 and v7|Stage IIB Breast Cancer AJCC v6 and v7|Stage IIIA Breast Cancer AJCC v7|Triple-Negative Breast Carcinoma
Interventions: BIOLOGICAL: Bevacizumab|DRUG: Carboplatin|DRUG: Cyclophosphamide|DRUG: Doxorubicin Hydrochloride|OTHER: Laboratory Biomarker Analysis|DRUG: Paclitaxel
Sponsor: National Cancer Institute (NCI)